About this trial
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.
Eligibility criteria
Qualifiers
19 years or older
Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
Living within British Columbia, Canada and in an area that is covered by Bell cellular network
Disqualifiers
Patient refusal
Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Medtronic - MITG
Lead sponsor
Excelar
Collaborator
Cloud DX Inc.
Collaborator
Bridge Health Solutions
Collaborator
Providence Healthcare
Collaborator